{"analyses":[{"groupIds":["OG000"],"nonInferiorityComment":"The association between response and Vp at Week 10 was evaluated.","nonInferiorityType":"OTHER","pValue":"0.0573","statisticalMethod":"Logistic Regression"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0024","value":"0.0081"},{"groupId":"OG001","spread":"0.0016","value":"0.0094"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0020","value":"0.0067"},{"groupId":"OG001","spread":"0.0022","value":"0.0077"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Day -2"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0027","value":"0.0070"},{"groupId":"OG001","spread":"0.0027","value":"0.0095"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0033","value":"0.0066"},{"groupId":"OG001","spread":"0.0029","value":"0.0089"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Day 5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0029","value":"0.0063"},{"groupId":"OG001","spread":"0.0032","value":"0.0069"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Week 5"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0044","value":"0.0060"},{"groupId":"OG001","spread":"0.0026","value":"0.0055"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Week 10"}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"description":"The fractional blood plasma volume (Vp) was used to evaluate clinical outcomes. The average for the distribution across the whole region of interest (ROI) was calculated as a summary measure for each data set.","dispersionType":"Standard Deviation","groups":[{"description":"Stratum A participants had primary tumors potentially resectable by aggressive surgery, such as limb-salvage surgery or amputation, and no evidence of metastasis.","id":"OG000","title":"A: Localized Resectable Disease"},{"description":"Stratum C participants had metastatic tumors.","id":"OG001","title":"C: Metastatic Tumors"}],"paramType":"MEAN","populationDescription":"The number analyzed at each time point differed due to missing observations at some of the time points","reportingStatus":"POSTED","timeFrame":"Baseline through Week 10","title":"Mean Vp","type":"SECONDARY","unitOfMeasure":"(unitless)"}